Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAlumasc Group Regulatory News (ALU)

Share Price Information for Alumasc Group (ALU)

Share Price is delayed by 15 minutes
Get Live Data
235.00    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 5.00 (2.083%)
Market Cap: £84.50m
ALU Live PriceLast checked at - London Stock Exchange

Intraday Alumasc Group Share Chart

Opening new Wade/Gatic building extension

4 Apr 2025 07:00

RNS Number : 6045D
Alumasc Group PLC (The)
04 April 2025
 

4 April 2025

The Alumasc Group plc

The RT Hon James Cleverly TD VR MP opening new Wade/Gatic building extension

Alumasc, the premium sustainable building products, systems and solutions group, is pleased to announce the formal opening of its Gatic access covers manufacturing and assembly facility at its site in Halstead, Essex. The Rt. Hon James Cleverly TD VR MP is visiting Alumasc's site in Halstead to open and record the historic transfer of the Gatic business to Halstead.

The move follows the investment of over £3 million in building work and new machinery, which improves manufacturing capability and efficiency, as well as simplifying product installation and further enhancing Gatic's environmental credentials. It will also continue to support Gatic's commitment to UK and international sales growth, thus far Gatic products have been supplied to projects in 114 countries, with the top four being: Hong Kong, Qatar, Singapore, UAE and Spain.

The Halstead site will become the manufacturing hub for Alumasc's market-leading Gatic and Wade brands. Gatic specialises in engineered access covers and surface water drainage products which are used to capture, control and return run-off safely into the natural water cycle. Wade manufactures a range of high-quality standard and bespoke drainage products including, floor gullies and gratings, linear drains and roof outlets for use in and around buildings. Concentrating drainage manufacturing at the Halstead site will allow for further investments to improve capacity and efficiency and accelerate new product development. 

The Rt Hon James Cleverly TD VR MP welcomed the innovation at the Halstead site and said:

"The relocation of UK manufacturing and assembly for the Gatic range to Alumasc's Halstead site is a major milestone. I am delighted to see Halstead emerging as a key hub for Alumasc's market-leading brands, supported by state-of-the-art facilities. This investment will drive growth, create jobs, and foster innovation, strengthening both the local economy and the wider manufacturing sector."

Paul Hooper, Chief Executive of The Alumasc Group said:

"This exciting move of Gatic covers manufacturing to Halstead represents a significant milestone in our journey towards greater innovation, growth, and enhanced product sustainability. The new location not only provides state-of-the-art facilities and enhanced machinery but also enables us to optimise our operations and expand our capabilities. I want to thank everyone involved with this project who helped make this move a reality".

END

 Enquiries:

 

The Alumasc Group plc

Paul Hooper (Chief Executive)

Simon Dray (Group Finance Director)

Helen Ashton (Group Company Secretary)

 

+44 (0)1536 383844

 

Camarco (Financial PR)

Ginny Pulbrook

Tilly Butcher

 

alumasc@camarco.co.uk

+44 (0)203 757 4980

 

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRAUPURPCUPAGAW
Date   Source Headline
6th May 20261:21 pmRNSHolding(s) in Company
21st Apr 20267:00 amRNSDirector Dealings
20th Apr 20262:37 pmRNSHolding(s) in Company
16th Apr 20267:00 amRNSQ3 Trading Update
1st Apr 20267:00 amRNSConfirmation of CEO appointment
9th Feb 20267:00 amRNS-RMelloMonday Investor Webinar
3rd Feb 20267:00 amRNSInterim Results
15th Jan 20267:00 amRNSDirectorate change
10th Dec 20259:36 amRNSNotice of Half Year Results
21st Nov 20252:17 pmRNSDirector/PDMR Shareholding
7th Nov 202511:22 amRNSDirector/PDMR Shareholding
5th Nov 20252:50 pmRNSDirector/PDMR Shareholding
4th Nov 202511:03 amRNSDirector/PDMR Shareholding
24th Oct 20251:52 pmRNSResult of AGM
24th Oct 20257:00 amRNSAGM Trading Update
23rd Sep 20257:00 amRNSCEO Retirement & 2025 AGM Notice & Annual Accounts
2nd Sep 20257:00 amRNSFinal Results - Unaudited
21st Jul 20257:00 amRNSNotice of FY Results and Investor Presentation
15th Jul 20257:00 amRNSFull Year Trading Update
11th Jun 20253:46 pmRNSDirector/PDMR Shareholding
27th May 20257:00 amRNSAppointment of Non-executive Director
4th Apr 20257:00 amRNS-ROpening new Wade/Gatic building extension
21st Mar 20257:00 amRNSAppointment of Joint Broker
12th Mar 202511:15 amRNSDirector/PDMR Shareholding
4th Feb 20257:00 amRNSHalf-year Results
27th Nov 202412:22 pmRNSNotice of Half Year Results
6th Nov 20241:40 pmRNSDirector/PDMR Shareholding
5th Nov 20248:00 amRNSDirector/PDMR Shareholding
1st Nov 202411:15 amRNSDirector/PDMR Shareholding
29th Oct 20247:00 amRNSDirector/PDMR Shareholding
24th Oct 20241:38 pmRNSResult of AGM
24th Oct 20247:00 amRNSAGM Trading Update
23rd Oct 202412:53 pmRNSDirector/PDMR Shareholding
10th Oct 20247:00 amRNSNotice of Capital Markets Event
4th Oct 20247:00 amRNSDirectorate Change
20th Sep 20242:15 pmRNSNotice of AGM
18th Sep 20242:32 pmRNSDirector/PDMR Shareholding
3rd Sep 20247:00 amRNSFinal Results
25th Jul 20248:00 amRNSNotice of Results
18th Jul 20247:00 amRNSFull Year Trading Update
25th Apr 20249:38 amRNSHolding(s) in Company
27th Feb 202412:31 pmRNSDirector/PDMR Shareholding
14th Feb 20241:01 pmRNSDirector/PDMR Shareholding
6th Feb 20247:00 amRNSInterim results
11th Jan 20247:00 amRNSNotice of Interim Results
3rd Jan 202412:52 pmRNSDirector/PDMR Shareholding
19th Dec 20239:50 amRNSDirector/PDMR Shareholding
18th Dec 20233:17 pmRNSDirector/PDMR Shareholding
18th Dec 20231:23 pmRNSDirector/PDMR Shareholding
18th Dec 20231:10 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.